Company Snapshot

Investment Thesis

Cencora (formerly AmerisourceBergen) distributes pharmaceuticals and specialty therapies globally. Specialty, biosimilars, and global logistics capabilities drive durable free cash flow.

  • Specialty Leadership: Oncology and physician-administered drugs grow faster than traditional retail.
  • Global Footprint: World Courier cold chain and Alliance Healthcare broaden reach.
  • Capital Allocation: Consistent buybacks and tuck-ins funded by strong cash conversion.

Strategic Mix

U.S. Healthcare Solutions Pharma distribution, specialty services
International Healthcare Solutions Alliance Healthcare wholesale, World Courier
Customer Mix Independent pharmacies, health systems, physician offices
Therapy Focus Oncology, animal health, biosimilars

Mix aligns with Cencora's U.S. and international segments and therapeutic focus.

Recent Performance

MTD TBD
QTD TBD
YTD TBD
5Y TBD

Maxim is cueing up returns data for this security. Once the nightly supported.csv job runs, these metrics will auto-populate.

Strategic Insights

Biosimilar Adoption

Education and access programs accelerate U.S. uptake.

Cold Chain Investments

World Courier capex supports cell & gene therapy logistics.

Data & Services

xPlore analytics and consulting deepen manufacturer partnerships.

Latest Coverage

Curated headlines sourced from Maxim’s AI newsroom.

Loading latest coverage...